Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 29, 2025	Mar. 30, 2024
Cash flows from operating activities:
Net income	$ 4,186	$ 3,952
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	424	332
Equity compensation expense from awards issued	773	635
Deferred income tax expense	(5)	49
Change in operating right of use assets	267	234
Changes in operating assets and liabilities:
Accounts receivable	9,558	(2,802)
Prepaid expenses and other current assets	1,787	120
Net of transit accounts receivable and payable	(4,393)	(219)
Accounts payable and accrued expenses	1,358	1,345
Accrued payroll and related costs	2,665	976
Right of use liabilities	(241)	(304)
Income taxes payable	71	(451)
Deferred revenue	356	1,633
Deposits	(4)	24
Total adjustments and changes in operating assets and liabilities	12,474	2,474
Net cash provided by operating activities	16,660	6,426
Cash flows from investing activities:
Property and equipment acquired	(427)	(669)
Net cash used in investing activities	(427)	(669)
Cash flows from financing activities:
Borrowings under line of credit	40,895	34,738
Repayments under line of credit	(52,448)	(43,383)
Issuance of stock for employee stock purchase plan	281	364
Retirement of common shares	(939)	(1,317)
Changes in finance lease obligations	(184)	(116)
Purchase of treasury stock	(3,188)	0
Net cash used in financing activities	(15,583)	(9,714)
Effect of exchange rate changes on cash and cash equivalents	(198)	(228)
Increase (decrease) in cash and cash equivalents	452	(4,185)
Cash and cash equivalents at beginning of period	4,729	6,284
Cash and cash equivalents at end of period	5,181	2,099
Supplemental cash flow information:
Interest	740	473
Income taxes	494	541
Non-cash operating activities:
Right of use assets in exchange for lease obligations	$ 233	$ 602